These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 23943221)
1. Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation. Spyropoulou A; Gargalionis A; Dalagiorgou G; Adamopoulos C; Papavassiliou KA; Lea RW; Piperi C; Papavassiliou AG Neuromolecular Med; 2014 Mar; 16(1):70-82. PubMed ID: 23943221 [TBL] [Abstract][Full Text] [Related]
2. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054 [TBL] [Abstract][Full Text] [Related]
3. Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20. Sepsa A; Levidou G; Gargalionis A; Adamopoulos C; Spyropoulou A; Dalagiorgou G; Thymara I; Boviatsis E; Themistocleous MS; Petraki K; Vrettakos G; Samaras V; Zisakis A; Patsouris E; Piperi C; Korkolopoulou P PLoS One; 2015; 10(1):e0115101. PubMed ID: 25602259 [TBL] [Abstract][Full Text] [Related]
4. Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1. Klonou A; Korkolopoulou P; Gargalionis AN; Kanakoglou DS; Katifelis H; Gazouli M; Chlamydas S; Mitsios A; Kalamatianos T; Stranjalis G; Themistocleous MS; Papavassiliou KA; Sgouros S; Papavassiliou AG; Piperi C Neurotherapeutics; 2021 Jul; 18(3):2073-2090. PubMed ID: 34296393 [TBL] [Abstract][Full Text] [Related]
5. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival. Lai X; Deng Z; Guo H; Zhu X; Tu W Cancer Biomark; 2017 Dec; 20(4):453-460. PubMed ID: 28946550 [TBL] [Abstract][Full Text] [Related]
6. Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Watanabe H; Soejima K; Yasuda H; Kawada I; Nakachi I; Yoda S; Naoki K; Ishizaka A Cancer Cell Int; 2008 Nov; 8():15. PubMed ID: 18980680 [TBL] [Abstract][Full Text] [Related]
7. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213 [TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570 [TBL] [Abstract][Full Text] [Related]
10. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258 [TBL] [Abstract][Full Text] [Related]
11. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival. Lai X; Deng Z; Guo H; Zhu X; Tu W Biochem Biophys Res Commun; 2017 Aug; 490(2):415-422. PubMed ID: 28623138 [TBL] [Abstract][Full Text] [Related]
12. SETDB1, HP1 and SUV39 promote repositioning of 53BP1 to extend resection during homologous recombination in G2 cells. Alagoz M; Katsuki Y; Ogiwara H; Ogi T; Shibata A; Kakarougkas A; Jeggo P Nucleic Acids Res; 2015 Sep; 43(16):7931-44. PubMed ID: 26206670 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308 [TBL] [Abstract][Full Text] [Related]
14. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Cai L; Ma X; Huang Y; Zou Y; Chen X Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085 [TBL] [Abstract][Full Text] [Related]
15. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related]
16. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Goyama S; Nitta E; Yoshino T; Kako S; Watanabe-Okochi N; Shimabe M; Imai Y; Takahashi K; Kurokawa M Leukemia; 2010 Jan; 24(1):81-8. PubMed ID: 19776757 [TBL] [Abstract][Full Text] [Related]
17. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates. Binda O; LeRoy G; Bua DJ; Garcia BA; Gozani O; Richard S Epigenetics; 2010; 5(8):767-75. PubMed ID: 21124070 [TBL] [Abstract][Full Text] [Related]
18. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Pogribny IP; Ross SA; Tryndyak VP; Pogribna M; Poirier LA; Karpinets TV Carcinogenesis; 2006 Jun; 27(6):1180-6. PubMed ID: 16497704 [TBL] [Abstract][Full Text] [Related]
19. A regulatory circuitry comprising TP53, Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425 [TBL] [Abstract][Full Text] [Related]
20. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors. Cai J; Chen J; Zhang W; Yang P; Zhang C; Li M; Yao K; Wang H; Li Q; Jiang C; Jiang T Oncotarget; 2015 Jul; 6(20):18105-15. PubMed ID: 25971279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]